Page last updated: 2024-08-25

bexarotene and 7-dehydrocholesterol

bexarotene has been researched along with 7-dehydrocholesterol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Arnold, LA; Ashton, JM; Battaglia, N; Dokholyan, NV; Fujihara, M; Gerber, SA; Hansen, JN; Hopson, R; Jian, Y; Jurutka, PW; Kakuta, H; Kawar, N; Khazan, N; Kim, KK; Kishor, K; Linehan, DC; Milano, MT; Miyamoto, H; Moore, RG; Moore, T; Nayak, S; Ojha, D; Pandita, R; Rowswell-Turner, RB; Schor, NF; Sharon, A; Singh, AP; Singh, NA; Singh, RK; Snyder, CWA; Strawderman, M; Tabdanov, ED; Takamura, Y; Teramoto, Y; Wang, J; Yano, N	1

Studies

Arnold, LA; Ashton, JM; Battaglia, N; Dokholyan, NV; Fujihara, M; Gerber, SA; Hansen, JN; Hopson, R; Jian, Y; Jurutka, PW; Kakuta, H; Kawar, N; Khazan, N; Kim, KK; Kishor, K; Linehan, DC; Milano, MT; Miyamoto, H; Moore, RG; Moore, T; Nayak, S; Ojha, D; Pandita, R; Rowswell-Turner, RB; Schor, NF; Sharon, A; Singh, AP; Singh, NA; Singh, RK; Snyder, CWA; Strawderman, M; Tabdanov, ED; Takamura, Y; Teramoto, Y; Wang, J; Yano, N

Other Studies

1 other study(ies) available for bexarotene and 7-dehydrocholesterol

Article	Year
Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors Journal of medicinal chemistry, 2022, 04-28, Volume: 65, Issue:8 Topics: Animals; Animals, Genetically Modified; Heterografts; Humans; Neuroblastoma; Receptors, Calcitriol; Vitamins	2022